EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.17 | 20(R)-ginsenoside Rg2 | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(R)-ginsenoside Rg3 | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(R)-ginsenoside Rh1 | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(R)-ginsenoside Rh2 | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(R)-protopanaxadiol | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(R)-protopanaxatriol | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(S)-ginsenoside Rg2 | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(S)-ginsenoside Rg3 | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(S)-ginsenoside Rh1 | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(S)-ginsenoside Rh2 | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(S)-protopanaxadiol | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | 20(S)-protopanaxatriol | reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition; reversible inhibition | Homo sapiens | |
2.4.1.17 | deoxyschizandrin | - |
Homo sapiens | |
2.4.1.17 | diclofenac | - |
Homo sapiens | |
2.4.1.17 | efavirenz | - |
Homo sapiens | |
2.4.1.17 | hecogenin | - |
Homo sapiens | |
2.4.1.17 | niflumic acid | - |
Homo sapiens | |
2.4.1.17 | nilotinib | - |
Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.4.1.17 | microsome | - |
Homo sapiens | - |
- |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.17 | Mg2+ | 5 mM used in assay conditions | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.17 | Homo sapiens | O60656 | - |
- |
2.4.1.17 | Homo sapiens | P16662 | - |
- |
2.4.1.17 | Homo sapiens | P19224 | - |
- |
2.4.1.17 | Homo sapiens | P22309 | - |
- |
2.4.1.17 | Homo sapiens | P22310 | - |
- |
2.4.1.17 | Homo sapiens | P35503 | - |
- |
2.4.1.17 | Homo sapiens | P54855 | - |
- |
2.4.1.17 | Homo sapiens | Q9HAW7 | - |
- |
2.4.1.17 | Homo sapiens | Q9HAW8 | - |
- |
2.4.1.17 | Homo sapiens | Q9HAW9 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.1.17 | intestine | - |
Homo sapiens | - |
2.4.1.17 | liver | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.17 | 4-methylumbelliferone + UDP-glucuronate | - |
Homo sapiens | UDP + 4-methylumbelliferyl beta-D-glucuronide | - |
? | |
2.4.1.17 | beta-estradiol + UDP-glucuronate | - |
Homo sapiens | UDP + beta-estradiol-3-glucuronide | - |
? | |
2.4.1.17 | chenodeoxycholic acid + UDP-glucuronate | - |
Homo sapiens | UDP + chenodeoxycholic acid 24-acyl-beta-D-glucuronide | - |
? | |
2.4.1.17 | propofol + UDP-glucuronate | - |
Homo sapiens | UDP + propofol O-glucuronide | - |
? | |
2.4.1.17 | serotonin + UDP-glucuronate | - |
Homo sapiens | UDP + serotonin O-glucuronide | - |
? | |
2.4.1.17 | trifluoperazine + UDP-glucuronate | - |
Homo sapiens | UDP + trifluoperazine N-glucuronide | - |
? | |
2.4.1.17 | zidovudine + UDP-glucuronate | - |
Homo sapiens | UDP + zidovudine-5'-glucuronide | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.1.17 | UDP-glucuronosyltransferase | - |
Homo sapiens |
2.4.1.17 | UGT1A1 | isoform | Homo sapiens |
2.4.1.17 | UGT1A10 | isoform | Homo sapiens |
2.4.1.17 | UGT1A3 | isoform | Homo sapiens |
2.4.1.17 | UGT1A4 | isoform | Homo sapiens |
2.4.1.17 | UGT1A6 | isoform | Homo sapiens |
2.4.1.17 | UGT1A7 | isoform | Homo sapiens |
2.4.1.17 | UGT1A8 | isoform | Homo sapiens |
2.4.1.17 | UGT1A9 | isoform | Homo sapiens |
2.4.1.17 | UGT2B15 | isoform | Homo sapiens |
2.4.1.17 | UGT2B7 | isoform | Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.4.1.17 | 0.000402 | - |
isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | niflumic acid | |
2.4.1.17 | 0.00104 | - |
isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | nilotinib | |
2.4.1.17 | 0.00585 | - |
isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.0064 | - |
isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | deoxyschizandrin | |
2.4.1.17 | 0.00677 | - |
isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | hecogenin | |
2.4.1.17 | 0.0104 | - |
isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | diclofenac | |
2.4.1.17 | 0.0114 | - |
isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.0117 | - |
isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.012 | - |
isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.0135 | - |
isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.0144 | - |
isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.015 | - |
isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.0186 | - |
isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.0197 | - |
isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.0206 | - |
isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.0209 | - |
isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.0231 | - |
isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.0236 | - |
isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.0238 | - |
isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.0243 | - |
isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.0256 | - |
isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.0259 | - |
isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.0262 | - |
isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.0262 | - |
isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.0268 | - |
isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.0287 | - |
isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.0289 | - |
isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | efavirenz | |
2.4.1.17 | 0.0296 | - |
isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.0319 | - |
isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.0324 | - |
isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.0379 | - |
isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.0448 | - |
isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.055 | - |
isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.0566 | - |
isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.0583 | - |
isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.0689 | - |
isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.0707 | - |
isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.0712 | - |
isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.0721 | - |
isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.0748 | - |
isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.0756 | - |
isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.077 | - |
isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.0809 | - |
isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.0915 | - |
isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A1, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A10, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A4, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg3 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A6, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A8, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxatriol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT1A9, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxatriol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B15, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg3 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(S)-ginsenoside Rh2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-protopanaxadiol | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rg2 | |
2.4.1.17 | 0.1 | - |
IC50 above 0.1 mM, isoform UGT2B7, at pH 7.4 and 37°C | Homo sapiens | 20(R)-ginsenoside Rh1 | |
2.4.1.17 | 0.1 | - |
IC50 below 0.1 mM, isoform UGT1A3, at pH 7.4 and 37°C | Homo sapiens | 20(S)-protopanaxadiol |